Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 20 EU countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of October 20th, we are planning to work on 21 projects, including:

Reimbursement

  1. Delivering reimbursement analysis for molecular diagnostic technologies in 12 European countries
  2. Delivering reimbursement analysis for an implantable device in the urology area in England, France, Germany, and Spain
  3. Working on market access strategy for the administration of a medication in outpatient settings in England, France, Germany, and Sweden
  4. Working on reimbursement analysis for cardiac devices in 10 European countries
  5. Working on reimbursement analysis for a minimally invasive orthopedic procedure in France
  6. Working on reimbursement analysis for a medical device used in gastrointestinal surgery in Belgium, England, France, and Italy 
  7. Working on reimbursement analysis for home-based in-vitro diagnostic tests in nine European countries 
  8. Working on reimbursement analysis for cancer treatment in Italy and Turkey 
  9. Working on reimbursement analysis for gastrointestinal minimally invasive surgery in England, France, Germany and Italy
  10. Working on reimbursement analysis for liver and kidney surgery in England, France, Germany and Italy
  11. Initiating work on reimbursement analysis for minimally invasive technology in urology area in eight European countries
  12. Initiating work on reimbursement analysis for cardiovascular and peripheral vascular procedures in Austria, Italy and Spain

HEOR

  1. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
  2. Working on a systematic review and meta-analysis for an in vitro diagnostic test
  3. Working on a clinical value dossier for an in vitro diagnostic test in the neurology area 
  4. Working on a systematic literature review update for a minimally invasive technology in the neurology area
  5. Working on evidence gap analysis for medical aids used in the urology area in France and Germany
  6. Working on evidence gap analysis for medical aids used in the gastrointestinal area in France and Germany
  7. Working on evidence gap analysis for a minimally invasive orthopedic procedure in France 
  8. Working on clinical value dossier for treatment technology in dermatology area
  9. Initiating work on literature review of treatment in urology area in European countries 

Let us know if you need any market access or HEOR support for your medical technology in Europe.